Metabolomic Technologies Inc. is a privately held company developing metabolomics-based in vitro diagnostics for cancer and other diseases. Our lead product PolypDx™ is a urine-based screening test for the detection of adenomatous polyps and colorectal cancer.
View Top Employees from Metabolomic Technologies Inc.| Website | http://mtidx.com |
| Revenue | $4 million |
| Funding | $4.2 million |
| Employees | 11 (11 on RocketReach) |
| Founded | 2010 |
| Address | E116 - 2011 94 Street NW, Edmonton, Alberta T6N 1H1, CA |
| Phone | (587) 772-1684 |
| Industry | Biotechnology Research, Business Services General, Diagnostics, Business Services, Metabolomics, Gastrointestinal Diseases, Colorectal Cancer |
| Web Rank | 18 Million |
| Keywords | Funding For Metabolomics Technologies Germany, Metabolomics |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325413 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Metabolomic Technologies Inc. employee's phone or email?
Metabolomic Technologies Inc. Questions
The Metabolomic Technologies Inc. annual revenue was $4 million in 2024.
Kevin Ens is the COO of Metabolomic Technologies Inc..
11 people are employed at Metabolomic Technologies Inc..
Metabolomic Technologies Inc. is based in Edmonton, Alberta.
The NAICS codes for Metabolomic Technologies Inc. are [325413, 32, 3254, 325, 32541].
The SIC codes for Metabolomic Technologies Inc. are [28, 283].
Top Metabolomic Technologies Inc. Employees
-
2
-
11
-
11
Related Companies
